TRIM25 and central nervous system cancer: Western blotting analysis of lysates from 19 primary tumors (WHO grades II-IV) and 4 NBT samples further confirmed the upregulation of TRIM25 in human gliomas (Fig. 1E, Supplementary Fig. S1B).